SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005794-05-000427
Filing Date
2005-05-16
Accepted
2005-05-16 16:14:18
Documents
1
Period of Report
2005-05-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 9750
  Complete submission text file 0001005794-05-000427.txt   11976
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Issuer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 340 EDGEMONT AVE SUITE 500 BRISTOL TN 37620 4239897211
GREGORY JOHN M (Reporting) CIK: 0001200376 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26372 | Film No.: 05834594

Mailing Address
Business Address 340 EDGEMONT AVE SUITE 500 BRISTOL TN 37620 4239897211
SJ STRATEGIC INVESTMENTS LLC (Reporting) CIK: 0001200378 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26372 | Film No.: 05834593